Filing Details
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
8k filedNASDAQ:ADGM
Adagio Medical Holdings, Inc. (ADGM) Reports Material Event to SEC
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
At publication ·
What changed
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Adagio Medical Holdings, Inc. (NASDAQ:ADGM) filed a Form 8-K with the SEC on August 11, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $0.72 with a market capitalization of $15.2 million.
- The specific nature of the material event is not disclosed in this article, though 8-K filings typically cover leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
Adagio Medical Holdings, Inc.'s stock currently trades at $0.72 with a market capitalization of $15.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Adagio Medical Holdings, Inc.'s stock.
All SEC filings for Adagio Medical Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ADGM Stock Page
Frequently Asked Questions
Where can I read ADGM's SEC filings?
Browse all filings on our ADGM SEC filings page.
What types of SEC filings does Adagio Medical Holdings, Inc. file?
Public companies like Adagio Medical Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.